EU medtech regulation text still needs more change, say MEPs
This article was originally published in SRA
Further changes are needed to the proposed EU Medical Device Regulation, warned members of the European Parliament from the European People’s Party Group following the 25 September vote by the Parliament's ENVI committee to carry through all 28 compromise amendments made to the text1,2.
You may also be interested in...
The UK responsible person is the UK equivalent of the Authorized Representative in the EU. MedTech Europe’s Jesús Rueda gives an update on the early experiences of medtech manufacturers seeking to comply with the UK’s new standalone regulations.
The European Commission has reluctantly allowed virtual audits in the context of new MDR and IVDR. The EU notified body association is helping the collective effort to meet its strict requirements.
The new EU MDR rules for economic operators are complex and burdensome for those not used to them. Chad Reynolds of RMQ+ outlines practical strategies for managing economic operators efficiently, and with a view to long-term compliance.